IM Cannabis Corp logo

IMCC

IM Cannabis Corp

$0.46

Earnings Summary

Revenue
$23.57Mn
Net Profits
$-9.45Mn
Net Profit Margins
-40.1%

Highlights

Revenue:

IM Cannabis Corp’s revenue jumped 168.84% since last year same period to $23.57Mn in the Q1 2022. On a quarterly growth basis, IM Cannabis Corp has generated 17.68% jump in its revenue since last 3-months.

Net Profits:

IM Cannabis Corp’s net profit fell -309.81% since last year same period to $-9.45Mn in the Q1 2022. On a quarterly growth basis, IM Cannabis Corp has generated 26.69% jump in its net profits since last 3-months.

Net Profit Margins:

IM Cannabis Corp’s net profit margin fell -178.04% since last year same period to -40.1% in the Q1 2022. On a quarterly growth basis, IM Cannabis Corp has generated 37.71% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the IM Cannabis Corp post its latest quarter earnings

EPS Estimate Current Quarter
-0.01
EPS Estimate Current Year
-0.01

Highlights

EPS Estimate Current Quarter:

IM Cannabis Corp’s earning per share (EPS) estimates for the current quarter stand at -0.01 - a 75% jump from last quarter’s estimates.

EPS Estimate Current Year:

IM Cannabis Corp’s earning per share (EPS) estimates for the current year stand at -0.01.

Key Ratios

Key ratios of the IM Cannabis Corp post its Q1 2022 earnings

Earning Per Share (EPS)
-0.14
Return on Assets (ROA)
-0.11
Return on Equity (ROE)
-0.21
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

IM Cannabis Corp’s earning per share (EPS) fell -133.33% since last year same period to -0.14 in the Q1 2022. This indicates that the IM Cannabis Corp has generated -133.33% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. IM Cannabis Corp’s return on assets (ROA) stands at -0.11.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. IM Cannabis Corp’s return on equity (ROE) stands at -0.21.

Dividend Per Share (DPS):

IM Cannabis Corp declared 0 dividend per share during the earnings announcement for Q1 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-03-31
-0.01
-0.14
-1300%

Company Information

IMC is an MCO in the medical cannabis sector headquartered in Israel and with operations In Israel and Germany. Over the past decade, the Company believes that the IMC brand has become synonymous with quality and consistency in the Israeli medical cannabis market. The Company has also expanded its business to offer intellectual property-related services to the medical cannabis industry. In Europe, IMC operates through Adjupharm GmbH ("Adjupharm"), a German-based subsidiary and EU-GMP certified medical cannabis distributor. IMC's European presence is augmented by strategic alliances with various pan-European EU-GMP cultivators and distributors to capitalize on the increased demand for medical cannabis products in Europe and bring the IMC brand and its product portfolio to European patients.

Organisation
IM Cannabis Corp
Employees
2.02K